| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30006414 | HIV | ENSG00000129484.14 | protein_coding | PARP2 | No | No | 10038 | Q9UGN5 |
| TVIS30035882 | HIV | ENSG00000129484.14 | protein_coding | PARP2 | No | No | 10038 | Q9UGN5 |
| TVIS30035883 | HIV | ENSG00000129484.14 | protein_coding | PARP2 | No | No | 10038 | Q9UGN5 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PARP2 |
|---|---|
| DrugBank ID | DB11793 |
| Drug Name | Niraparib |
| Target ID | BE0003798 |
| UniProt ID | Q9UGN5 |
| Regulation Type | inhibitor |
| PubMed IDs | 30073633 |
| Citations | Heo YA, Duggan ST: Niraparib: A Review in Ovarian Cancer. Target Oncol. 2018 Aug;13(4):533-539. doi: 10.1007/s11523-018-0582-1. |
| Groups | Approved; Investigational |
| Direct Classification | Phenylpiperidines |
| SMILES | NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1 |
| Pathways | |
| PharmGKB | PA166131610 |
| ChEMBL | CHEMBL1094636 |
